In our initial study of the impact of MSI-1436 on PTP1B in models of breast cancer, we reported a double-mutant, PTP1B-L192A/S372P, in which catalytic function was preserved but inhibition by MSI-1436 was abrogated (19). Here, PTPN1 is linked to breast carcinoma.